Ignite Creation Date:
2024-05-06 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03603184
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-13
First Post:
2018-05-21
Brief Title:
Atezolizumab Trial in Endometrial Cancer - AtTEnd
Sponsor:
Mario Negri Institute for Pharmacological Research
Organization:
Mario Negri Institute for Pharmacological Research
Organization Data
Organization:
Mario Negri Institute for Pharmacological Research
Class:
OTHER
Study ID:
IRFMN-EN-7556
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |